Search

Search Results
Results 11 - 20 of 88 for Refractories
  • Supplier Profile
    InRedox develops, designs and manufactures nanostructured materials and components based on self-organized nanoporous Anodic Aluminum Oxide (AAO) and nanotubular Anodic Titanium Oxide (ATO) –...
  • Supplier Profile
    Both departments in the College of Chemistry rank among the most prominent in their fields, and both are renowned for their breadth of activity in a diverse range of subdisciplines and applications....
  • Supplier Profile
    Teledyne Leeman Labs is the analytical instrument company that more corporations, government agencies, municipalities, and educational institutions are choosing to do business with – across the...
  • Supplier Profile
    Sigma-Aldrich® is a leading high-technology company. Through our Materials Chemistry Centers of Excellence in research and manufacturing we develop advanced, enabling materials for your...
  • Supplier Profile
    Reinste Nano Ventures emphases the significance of purest Nanomaterials with uniform composition free from any adulterants for class research and production purposes. In Reinste Nano ventures we...
  • Supplier Profile
    Nanostructured & Amorphous Materials Inc. (NanoAmor) was founded in Los Alamos, New Mexico, USA, in September 2001. NanoAmor is a leading nanomaterials company, involved in all aspects of the...
  • Supplier Profile
    PlasmaChem GmbH was founded 1993 in Mainz. In 2005 the company moved from Mainz to Berlin and is now located in the district Adlershof - the "City of Science and Media" —...
  • News - 28 Mar 2014
    Celator Pharmaceuticals, Inc., a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that patients have been enrolled in an investigator-initiated...
  • Article - 6 Apr 2005
    Scientists working on pellistor gas sensors have made a micromachined pellistor structure with low power consumption and a controllable catalyst structure. The production process involved the...
  • News - 2 Jun 2015
    Dicerna Pharmaceuticals, Inc., a leader in the development of RNAi therapeutics, today presented preliminary safety and efficacy data from an ongoing Phase 1 study of DCR-MYC in patients with advanced...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.